Table of Contents
Introduction and Abbreviations
-
- Introduction
- Other relevant reports
- Definition
-
- Figure 1: Products covered in this report with some conditions the products treat
- Abbreviations & terms
- Abbreviations
- Terms
Executive Summary
-
- Medicated skincare has sales of $1,676 million
- Prevalence and tendency to treat
- Population shifts drive sales
- Consumers willing to pay more for new, superior treatments
- Medicated skincare products face competition on several fronts
- Private label sales suggest some perceived parity
- Natural products show gains, if effective
- Since 2002, wart and acne treatments show greatest growth of the seven segments
- Vanity and self-image drive desire for fast working formulas
- Pfizer leads the category, followed closely by J&J and Schering-Plough
- Drug stores gaining share of sales
- Men more apt to have cuts/scrapes
- Medicated skincare products have an opportunity to build lifetime value
- Future fragmentation of the market with more focus on seniors and kids
- Medicated skincare to grow slightly in constant terms
Market Drivers
-
- Introduction
- The prevalence of skin problems and the likelihood to treat them
-
- Figure 2: Suffered from various skin conditions in the past 3 months, January 2005
-
- Figure 3: Reasons for using first aid products, July 2002
-
- Figure 4: Consumers’ response to various skin ailments, January 2005
-
- Figure 5: Tendency for sufferers of specific skin problems to “do nothing and live with it,” January 2005
- Population shifts influencing demand for medicated skincare products
-
- Figure 6: U.S. population projections, 2000, 2005 and 2010
-
- Figure 7: U.S. Female population projections, 2000, 2005, and 2010
- Product innovation in OTC medicated skincare
- Competition for the category
- Competition from combination products
- Competition from prescription drugs
- Competition from non-medicating products/procedures
- Increasing number of diabetics
Market Size & Trends
-
-
- Figure 8: FDM sales of medicated skincare, at current and constant prices, 1999-2004
-
- Figure 9: Graph: FDM sales of medicated skincare products, at current and constant prices, 1999-2004
- Market Trends
- Some blurring of medicine and cosmetics
- More “natural” medicated skincare products
- Kid specific products
- Evidence of some perceived parity between private labels and brands
-
- Figure 10: Private label sales for products treating specific skin conditions in FDM channels
-
Market Segmentation
-
- Overview
-
- Figure 11: U.S. sales of medicated skincare products, by segment, 2002 & 2004
- First aid ointments/antiseptics
-
- Figure 12: Sales of first aid ointments/antiseptics, at current and constant prices, 1999-2004
- Anti-itch treatments
-
- Figure 13: Sales of anti-itch treatments, at current and constant prices, 1999-2004
- Acne treatments
-
- Figure 14: Sales of acne treatments, at current and constant prices, 1999-2004
- Lip balm/cold sore medications
-
- Figure 15: Sales of lip balm/cold sore medications, at current and constant prices, 1999-2004
- Athlete’s foot medication
-
- Figure 16: Sales of foot care/athlete’s foot medication, at current and constant prices, 1999-2004
- Wart removers
-
- Figure 17: Sales of wart removers, at current and constant prices, 1999-2004
- Lice treatments
-
- Figure 18: Sales of lice treatments, at current and constant prices, 1999-2004
Supply Structure
-
- Companies and brands
-
- Figure 19: Manufacturer sales of medicated skincare in the U.S., 2002 & 2004
- First aid ointments/topical antiseptics
-
- Figure 20: Manufacturer brand sales of first aid ointments/antiseptics in the U.S., 2002 & 2004
- Anti-Itch treatments
-
- Figure 21: Manufacturer brand sales of anti-itch treatments in the U.S., 2002 & 2004
- Acne treatments
-
- Figure 22: Manufacturer brand sales of acne treatments in the U.S., 2002 & 2004
- Lip balm/cold sore medication
-
- Figure 23: Manufacturer brand sales of lip balm/cold sore medication in the U.S., 2002 & 2004
- Foot care/athlete’s foot medications
-
- Figure 24: Manufacturer brand sales foot care/athlete’s foot medications in the U.S., 2002 & 2004
- Wart removers
-
- Figure 25: Manufacturer brand sales of wart removers in the U.S., 2002 & 2004
- Lice treatments
-
- Figure 26: Manufacturer brand sales of lice treatments in the U.S., 2002 & 2004
- Major manufacturers
- Introduction
- Pfizer
- Johnson & Johnson
- Schering-Plough
- Wyeth
- GlaxoSmithKline
Advertising & Promotion
-
- Pfizer
- Johnson & Johnson
- Schering-Plough
- Wyeth
Retail Distribution
-
- Introduction
-
- Figure 27: U.S. retail sales of medicated skincare products, by channel, 2002 & 2004
- Drug stores
-
- Figure 28: U.S. drug store sales of medicated skincare products, at current and constant prices, 1999-2004
- Supermarkets
-
- Figure 29: U.S. supermarket sales of medicated skincare products, at current and constant prices, 1999-2004
- Mass-merchandisers
-
- Figure 30: U.S. mass merchandiser sales of medicated skincare products, at current and constant prices, 1999-2004
The Consumer
-
- Introduction
- Adult usage of medicated skincare products
- Overview
-
- Figure 31: Usage of medicated skincare products, first aid bandages, and topical antibiotic remedies, January 2004-September 2004
- First aid products, topical antibiotics
-
- Figure 32: Use of first aid bandages and topical antibiotic remedies, January 2004-September 2004
-
- Figure 33: Use of first aid bandages and topical antibiotic remedies by gender, January 2004-September 2004
-
- Figure 34: Use of first aid bandages and topical antibiotic remedies by presence of children, January 2004-September 2004
-
- Figure 35: Use of first aid bandages and topical antibiotic remedies by age, January 2004-September 2004
-
- Figure 36: Use of first aid bandages and topical antibiotic remedies by household income, January 2004—September 2004
-
- Figure 37: Use of first aid bandages and topical antibiotic remedies by race/ethnicity, January 2004 to September 2004
- Prevalence of skin conditions
-
- Figure 38: Suffered from various skin conditions in the past 3 months, January 2005
-
- Figure 39: Suffered from various skin conditions in the past three months, by gender, January 2005
-
- Figure 40: Suffered from various skin conditions in the past 3 months, by age, January 2005
- Steps taken when suffering from specific skin conditions
- Steps taken for minor cuts/scrapes
-
- Figure 41: Steps taken for minor cuts and scrapes, by gender, January 2005
-
- Figure 42: Steps taken for minor cuts and scrapes, by age, January 2005
-
- Figure 43: Steps taken for minor cuts and scrapes by household income, January 2005
- Steps taken for dry or chapped skin
-
- Figure 44: Steps taken for dry, chapped, or cracking skin, by gender, January 2005
- Steps taken for rashes and skin itches
-
- Figure 45: Steps taken for minor rashes or skin itches, by gender, January 2005
- Steps taken to treat acne
-
- Figure 46: Steps taken for acne or blackheads, January 2005
- Steps taken to treat cold sores
-
- Figure 47: Steps taken for cold sores, January 2005
- Attitudes toward medicated skincare products
-
- Figure 48: Attitudes about medicated skincare, January 2005
-
- Figure 49: Attitudes about medicated skincare, by age, January 2005
-
- Figure 50: Attitudes about medicated skincare, by race, January 2005
- Teenagers’ use of medicated skincare products
-
- Figure 51: Usage of medicated skincare products for acne by teens, January 2004-December 2004
-
- Figure 52: Number of time s used an acne remedy in the last seven days, by teens
- Kids’ use of medicated skincare products
-
- Figure 53: Usage of medicated skincare products among kids
- Summary
Future & Forecast
-
- Future trends
- Prescriptions become OTCs
- Further fragmentation of the market with more targeting by age
- Oral OTC skincare
- Extension of natural treatments
-
- Figure 54: Sales of homeopathic skin topical, 1999-2004
- Market forecast
- Medicated skincare
-
- Figure 55: Forecast of U.S. FDM sales of medicated skincare, at current and constant prices, 2004-2009
- First aid ointments/antiseptics
-
- Figure 56: Forecast of U.S. FDM sales of first aid ointments/antiseptics, at current and constant prices, 2004-2009
- Anti-itch treatments
-
- Figure 57: Forecast of U.S. FDM sales of anti-itch treatments, at current and constant prices, 2004-2009
- Acne treatments
-
- Figure 58: Forecast of U.S. FDM sales of acne treatments, at current and constant prices, 2004-2009
- Lip balm/cold sore medications
-
- Figure 59: Forecast of U.S. FDM sales of lip balm/cold sore medications, at current and constant prices, 2004-2009
- Foot care/athlete’s foot medication
-
- Figure 60: Forecast of U.S. FDM sales of foot care/athlete’s foot medication, at current and constant prices, 2004-2009
- Wart removers
-
- Figure 61: Forecast of U.S. FDM sales of wart removers, at current and constant prices, 2004-2009
- Forecast Factors
Appendix: Trade Associations
Appendix: New Product Developments
-
- Wal-Mart: Equate Wart Remover
- Vitacilina: Derman Anti-fungal Foot Cream
- Medtech: Compound W Wart Remover for Kids
- Johnson & Johnson: Daily Cleansing Pads
- Blistex: Medicated Berry Balm
- Woodridge Labs: SafeTek Lice Removal Kit
Back to top